XML 38 R16.htm IDEA: XBRL DOCUMENT v3.24.3
LOAN PAYABLE
12 Months Ended
Jul. 31, 2024
Debt Disclosure [Abstract]  
LOAN PAYABLE [Text Block]

10. LOAN PAYABLE

On September 3, 2019, the Company completed a debt financing with Eridanus Capital LLC (the "Lender") for $1,000,000 (the "Loan"). The Loan has a term of 4 years and an annual interest rate of 10% for the first two years increasing to 20% in year 3 and to 25% in year 4. Interest will accrue and be paid along with the principal upon the maturity date. The Lender received 1,150,000 bonus share purchase warrants as additional consideration for advancing the Loan. The fair value of these warrants was calculated to be $444,942 which was netted against the loan payable balance along with $15,000 paid to the lender for a total of $459,942 in issuance costs. Each warrant entitles the holder to acquire one share of common stock at an exercise price of $0.80 (C$1.00) for a period of three years from the date of issuance. The Loan may be repaid prior to the maturity date, in whole or in part, provided that all accrued interest is paid. In addition, if total interest payments are less than $200,000, the difference will be paid to the Lender as prepayment compensation. The Loan is secured against the assets of the Company and its subsidiary and will be used for permitting, engineering, and working capital at the Company's Idaho Maryland Gold Project.

    Loan Payable  
Balance, July 31, 2022 $ 1,364,530  
Interest expense   328,097  
Accretion expense   149,505  
Issuance costs   (154,218 )
Repayment   (250,000 )
Balance, July 31, 2023 $ 1,437,914  
Interest expense   299,228  
Accretion expense   120,918  
Repayment   (200,000 )
Balance, July 31, 2024 $ 1,658,060  

In February 2023, the Company renegotiated its debt agreement with the Lender whereby the Company agreed to pay $250,000 applied against unpaid and accrued interest and issue 575,000 share purchase warrants to the Lender. The maturity date of the loan was extended by one year to September 4, 2024 and the interest rate was reduced to 15% compounding monthly for a period of 12 months after which it reverted to 25% per annum, compounding monthly. The renegotiation of the debt was accounted for as a non - substantial debt modification. Accordingly, no gain or loss was recorded and a new effective interest rate of 32.67% was established based on the carrying value of the debt and the revised cash flow. Each warrant entitles the holder to acquire one share at an exercise price of $0.60 for a period of two years from the date of issuance. The fair value of these warrants was calculated to be $154,218 which was netted against the loan payable balance.

The following weighted average assumptions were used for the Black-Scholes pricing model valuation of warrants:

  February 17, 2023
   
Risk-free interest rate 4.15%
Expected life of warrants 2 years
Expected annualized volatility 99.02%
Share price at grant date $0.53
Exercise price $0.60
Fair value $0.27
Dividend Nil
Forfeiture rate 0%